Membrane microparticles in VTE and cancer

Thrombosis Research

Volumn 125, Issue , 2010, Pages S80-S83

  Key, Nigel S ^a   Chantrathammachart, Pichika ^a   Moody, Patrick W ^a   Chang, Jen Yea ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Microparticle; Thrombosis; Tissue factor

Indexed keywords

ANIMAL; HUMAN; MEMBRANE MICROPARTICLE; NEOPLASM; PATHOLOGY; REVIEW; THROMBOSIS;

ANIMALS; CELL-DERIVED MICROPARTICLES; HUMANS; NEOPLASMS; THROMBOSIS;

EID: 77955508425     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/S0049-3848(10)70020-7     Document Type: Article

References (45)

1. Davila, M, Amirkhosravi, A, Coll, E, Desai, H, Robles, L, Colon, J, et al. Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation. J Thromb Haemost 6:9 (2008 Sep), 1517–1524.
2. Dasgupta, SK, Abdel-Monem, H, Niravath, P, Le, A, Bellera, RV, Langlois, K, et al. Lactadherin and clearance of platelet-derived microvesicles. Blood 113:6 (2009 Feb 5), 1332–1339.
3. Johnstone, RM, Exosomes biological significance: A concise review. Blood Cells Mol Dis 36:2 (2006 Mar-Apr), 315–321.
4. Thery, C, Zitvogel, L, Amigorena, S, Exosomes: composition, biogenesis and function. Nat Rev Immunol 2:8 (2002 Aug), 569–579.
5. Flaumenhaft, R, Dilks, JR, Richardson, J, Alden, E, Patel-Hett, SR, Battinelli, E, et al. Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles. Blood 113:5 (2009 Jan 29), 1112–1121.
6. Chironi, GN, Boulanger, CM, Simon, A, Dignat-George, F, Freyssinet, JM, Tedgui, A, Endothelial microparticles in diseases. Cell Tissue Res 335:1 (2009 Jan), 143–151.
7. Castellana, D, Kunzelmann, C, Freyssinet, JM, Pathophysiologic significance of procoagulant microvesicles in cancer disease and progression. Hamostaseologie 29:1 (2009 Jan), 51–57.
8. Davizon, P, Lopez, JA, Microparticles and thrombotic disease. Curr Opin Hematol 16:5 (2009 Sep), 334–341.
9. Nomura, S, Ozaki, Y, Ikeda, Y, Function and role of microparticles in various clinical settings. Thromb Res 123:1 (2008), 8–23.
10. Dvorak, HF, Quay, SC, Orenstein, NS, Dvorak, AM, Hahn, P, Bitzer, AM, et al. Tumor shedding and coagulation. Science 212:4497 (1981 May 22), 923–924.
11. Dvorak, HF, Van DeWater, L, Bitzer, AM, Dvorak, AM, Anderson, D, Harvey, VS, et al. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells. Cancer Res 43:9 (1983 Sep), 4434–4442.
12. Ratajczak, J, Wysoczynski, M, Hayek, F, Janowska-Wieczorek, A, Ratajczak, MZ, Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20:9 (2006 Sep), 1487–1495.
13. Valadi, H, Ekstrom, K, Bossios, A, Sjostrand, M, Lee, JJ, Lotvall, JO, Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:6 (2007 Jun), 654–659.
14. Al-Nedawi, K, Meehan, B, Micallef, J, Lhotak, V, May, L, Guha, A, et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol 10:5 (2008 May), 619–624.
15. Al-Nedawi, K, Meehan, B, Kerbel, RS, Allison, AC, Rak, J, Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc Natl Acad Sci USA 106:10 (2009 Mar 10), 3794–3799.
16. Hong, BS, Cho, JH, Kim, H, Choi, EJ, Rho, S, Kim, J, et al. Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells. BMC Genomics, 10, 2009, 556.
17. Skog, J, Wurdinger, T, van Rijn, S, Meijer, DH, Gainche, L, Sena-Esteves, M, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10:12 (2008 Dec), 1470–1476.
18. Milsom, CC, Yu, JL, Mackman, N, Micallef, J, Anderson, GM, Guha, A, et al. Tissue factor regulation by epidermal growth factor receptor and epithelial-to-mesenchymal transitions: effect on tumor initiation and angiogenesis. Cancer Res 68:24 (2008 Dec 15), 10068–10076.
19. Jenkins, EO, Schiff, D, Mackman, N, Key, NS, Venous thromboembolism in malignant gliomas. J Thromb Haemost 8:2 (2010), 221–227.
20. Robert, S, Poncelet, P, Lacroix, R, Arnaud, L, Giraudo, L, Hauchard, A, et al. Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies?. J Thromb Haemost 7:1 (2009 Jan), 190–197.
21. Lawrie, AS, Albanyan, A, Cardigan, RA, Mackie, IJ, Harrison, P, Microparticle sizing by dynamic light scattering in fresh-frozen plasma. Vox Sang 96:3 (2009 Apr), 206–212.
22. Xiong, G, Aras, O, Shet, A, Key, NS, Arriaga, EA, Analysis of individual platelet-derived microparticles, comparing flow cytometry and capillary electrophoresis with laser-induced fluorescence detection. Analyst 128:6 (2003 Jun), 581–588.
23. Zwicker, JI, Liebman, HA, Neuberg, D, Lacroix, R, Bauer, KA, Furie, BC, et al. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res 15:22 (2009 Nov 15), 6830–6840.
24. Yuana, Y, Oosterkamp, TH, Bahatyrova, S, Ashcroft, B, Garcia Rodriguez, P, Bertina, RM, et al. Atomic force microscopy: a novel approach to detect nanosized blood microparticles. J Thromb Haemost 8:2 (2010), 315–323.
25. Freyssinet, JM, Toti, F, Membrane microparticle determination: at least seeing what's being sized. J Thromb Haemost 8:2 (2010), 311–314.
26. Dignat-George, F, Freyssinet, JM, Key, NS, Centrifugation is a crucial step impacting microparticle measurement. Platelets 20:3 (2009 May), 225–226 author reply 7–8.
27. Nomura, S, Shouzu, A, Taomoto, K, Togane, Y, Goto, S, Ozaki, Y, et al. Assessment of an ELISA Kit for Platelet-Derived Microparticles by Joint Research at Many Institutes in Japan. J Atheroscler Thromb, 2009 Dec 22.
28. Aupeix, K, Hugel, B, Martin, T, Bischoff, P, Lill, H, Pasquali, JL, et al. The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. J Clin Invest 99:7 (1997 Apr 1), 1546–1554.
29. Aras, O, Shet, A, Bach, RR, Hysjulien, JL, Slungaard, A, Hebbel, RP, et al. Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. Blood 103:12 (2004 Jun 15), 4545–4553.
30. Manly, DA, Wang, J, Glover, SL, Kasthuri, R, Liebman, HA, Key, NS, et al. Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism. Thromb Res, 2009 Oct 24.
31. Amin, C, Mackman, N, Key, NS, Microparticles and cancer. Pathophysiol Haemost Thromb 36:3–4 (2008), 177–183.
32. Zwicker, JI, Tissue factor-bearing microparticles and cancer. Semin Thromb Hemost 34:2 (2008 Mar), 195–198.
33. Hron, G, Kollars, M, Weber, H, Sagaster, V, Quehenberger, P, Eichinger, S, et al. Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer. Thromb Haemost 97:1 (2007 Jan), 119–123.
34. Tesselaar, ME, Romijn, FP, Van Der Linden, IK, Prins, FA, Bertina, RM, Osanto, S, Microparticle-associated tissue factor activity: a link between cancer and thrombosis?. J Thromb Haemost 5:3 (2007 Mar), 520–527.
35. Trappenburg, MC, van Schilfgaarde, M, Marchetti, M, Spronk, HM, ten Cate, H, Leyte, A, et al. Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia. Haematologica 94:7 (2009 Jul), 911–918.
36. Schwertz, H, Tolley, ND, Foulks, JM, Denis, MM, Risenmay, BW, Buerke, M, et al. Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenicity of human platelets. J Exp Med 203:11 (2006 Oct 30), 2433–2440.
37. Panes, O, Matus, V, Saez, CG, Quiroga, T, Pereira, J, Mezzano, D, Human platelets synthesize and express functional tissue factor. Blood 109:12 (2007 Jun 15), 5242–5250.
38. Osterud, B, Bjorklid, E, Sources of tissue factor. Semin Thromb Hemost 32:1 (2006 Feb), 11–23.
39. Key, NS, Platelet tissue factor: how did it get there and is it important?. Semin Hematol 45:2 Suppl 1 (2008 Apr), S16–S20.
40. Poste, G, Nicolson, GL, Arrest and metastasis of blood-borne tumor cells are modified by fusion of plasma membrane vesicles from highly metastatic cells. Proc Natl Acad Sci USA 77:1 (1980 Jan), 399–403.
41. Nieuwland, R, Cellular origin of microparticles exposing tissue factor in cancer: a mixed double?. J Thromb Haemost 6:9 (2008 Sep), 1514–1516.
42. Furie, B, Furie, BC, Mechanisms of thrombus formation. N Engl J Med 359:9 (2008 Aug 28), 938–949.
43. Thomas, GM, Panicot-Dubois, L, Lacroix, R, Dignat-George, F, Lombardo, D, Dubois, C, Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo. J Exp Med 206:9 (2009 Aug 31), 1913–1927.
44. Yu, JL, May, L, Lhotak, V, Shahrzad, S, Shirasawa, S, Weitz, JI, et al. Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood 105:4 (2005 Feb 15), 1734–1741.
45. Khorana, AA, Francis, CW, Menzies, KE, Wang, JG, Hyrien, O, Hathcock, J, et al. Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer. J Thromb Haemost 6:11 (2008 Nov), 1983–1985.